Landlocked developing countries (LLDCs) vs Slovakia: Proportion of the target population who received a 3rd dose
Landlocked developing countries (LLDCs)
76.0%
in 2024
Slovakia
96.0%
in 2024
Landlocked developing countries (LLDCs) rank
17th
Slovakia rank
16th
Proportion of the target population who received a 3rd dose over time
- Landlocked developing countries (LLDCs)
- Slovakia
How they compare
Slovakia currently reports 96.0% against 76.0% in Landlocked developing countries (LLDCs), a difference of 20.0%.
That makes Slovakia's figure about 1.3 times Landlocked developing countries (LLDCs)'s.
Across all 15 years both countries report, Slovakia has been ahead every year.
Landlocked developing countries (LLDCs) ranks 17th and Slovakia ranks 16th of 36 groups.
Slovakia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.0% | 97.3% | 53.3% | Slovakia |
| 2020s | 72.2% | 96.2% | 24.0% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Landlocked developing countries (LLDCs) or Slovakia?
- Slovakia, at 96.0% against 76.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Landlocked developing countries (LLDCs) and Slovakia?
- 20.0%, with Slovakia ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Slovakia?
- 15 years are reported by both, from 2010 to 2024.
- How do Landlocked developing countries (LLDCs) and Slovakia rank globally for proportion of the target population who received a 3rd dose of?
- Landlocked developing countries (LLDCs) ranks 17th and Slovakia ranks 16th of 36 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.